Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
INMD compared with PCRX: revenue, margins and what each company keeps, and the suppliers and customers both name
INMD
InMode Ltd.
Change
Mkt cap
Revenue
Revenue
PCRX
Pacira BioSciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
INMD
InMode Ltd.
vs
PCRX
Pacira BioSciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
INMD: latest quarter not drawable.
Method
›
INMD
InMode Ltd.
Change
14.34
▲
+1.85%
Mkt cap
$892.1M
Revenue
—
Revenue
—
PCRX
Pacira BioSciences, Inc.
Change
36.39
0.00%
Regular session
Nov 4 '26
Mkt cap
$1.5B
Revenue
$192M
Q2 FY26
Revenue
$726M
FY25
vs
Compare
Regular session
Nov 4 '26
INMD
InMode Ltd.
vs
PCRX
Pacira BioSciences, Inc.
14.34
▲
+1.85%
Price
36.39
0.00%
$892.1M
Mkt cap
$1.5B
—
Revenue
$192M
Q2 FY26
—
Revenue
$726M
FY25
Change
Change
INMD
14.34
▲
+1.85%
vs
PCRX
36.39
0.00%
Regular session
Nov 4 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only INMD
0
None
Shared
0
No disclosed counterparties: INMD.
Only PCRX
12
MCK
McKesson Drug
customer
CAH
Cardinal Health
customer
—
AmerisourceBergen Health
unlisted
customer
JNJ
Johnson & Johnson MedTech
supplier
8 more · PCRX chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
INMD, solid
PCRX, dashed